Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery.

Area of Science:

• Nanotechnology in drug delivery
• Materials science of lipid-based carriers

Background:

• Solid Lipid Nanoparticles (SLN) emerged as advanced lipid-based nanocarriers, succeeding liposomes.
• SLN are colloidal dispersions utilizing a solid biodegradable lipid matrix for drug encapsulation.

Purpose of the Study:

• To provide a comprehensive overview of Solid Lipid Nanoparticles (SLN).
• To discuss SLN manufacturing techniques, advantages, and limitations.
• To introduce Nanostructured Lipid Carriers (NLC) as an improved generation of lipid nanocarriers.

Main Methods:

• Review of established manufacturing processes for SLN, including solvent diffusion and high-pressure homogenization.
• Exploration of various administration routes for SLN (oral, parenteral, pulmonary).
• Discussion of characterization techniques for evaluating SLN and NLC properties.

Main Results:

• SLN offer significant benefits such as controlled drug release, increased bioavailability, and protection of labile compounds.
• SLN manufacturing employs both high and low shear mixing techniques.
• Nanostructured Lipid Carriers (NLC) address SLN limitations, particularly in drug loading capacity and storage stability.

Conclusions:

• Solid Lipid Nanoparticles (SLN) are versatile nanocarriers with broad applications in pharmaceuticals.
• Nanostructured Lipid Carriers (NLC) offer enhanced drug loading and improved stability over traditional SLN.
• Further research into SLN and NLC characterization and application is warranted.